Results after implementation of the European protocol in the management of post-TAVI conduction disorders.

REC Interv Cardiol · 2025 · PMC12118562 · PMID 40438643

Europe PMC DOI

hedged sentence

0.8310

closest p · 16.6× alpha

0.8310

boldest claim

The sentences

did not reach statistical significanceP = .831not close (p > 0.1)

However, this difference did not reach statistical significance for pacemaker indication due to RBBB with additional conduction disorders (46.8% vs 32.9%; P = .831).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.